Low Molecular Weight Heparin Is Superior for Venous Thromboembolism Prophylaxis in High-Risk Geriatric Patients
The American Surgeon™ · 2023
DOI: 10.1177/00031348231177922 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, 2023. Verfasst von Christina M Deusenberry und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, West Virginia University, Morgantown, WV, USA. Hauptthemen laut MEDLINE: Venous Thromboembolism, Pulmonary Embolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Institute of General Medical Sciences.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Introduction
Venous thromboembolism (VTE) is a source of preventable morbidity and mortality in critically ill trauma patients. Age is one independent risk factor. Geriatric patients embody a population at high thromboembolic and hemorrhagic risk. Currently, there is little guidance between low molecular weight heparin (LMWH) and unfractionated heparin (UFH) for anticoagulant prophylaxis in the geriatric trauma patient.
Methods
A retrospective review was conducted at an ACS verified, Level I Trauma center from 2014 to 2018. All patients 65 years or older, with high-risk injuries and admitted to the trauma service were included. Choice of agent was at provider discretion. Patients in renal failure, or those that received no chemoprophylaxis, were excluded. The primary outcomes were the diagnosis of deep vein thrombosis or pulmonary embolism and bleeding associated complications (gastrointestinal bleed, TBI expansion, hematoma development).
Results
This study evaluated 375 subjects, 245 (65%) received enoxaparin and 130 (35%) received heparin. DVT developed in 6.9% of UFH patients, compared to 3.3% with LMWH ( P = .1). PE was present in 3.8% of UFH group, but only .4% in the LMWH group ( P = .01). Combined rate of DVT/PE was significantly lower ( P = .006) with LMWH (3.7%) compared to UFH (10.8%). 10 patients had documented bleeding events, and there was no significant association between bleeding and the use of LMWH or UFH.
Conclusions
VTE events are more common in geriatric patients treated with UFH compared to LMWH. There was no associated increase in bleeding complications when LMWH was utilized. LMWH should be considered the chemoprophylatic agent of choice in high risk geriatric trauma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, West Virginia University, Morgantown, WV, USA.
- Department of Surgery, West Virginia University, Morgantown, WV, USA.
- Department of Statistic, West Virginia University, Morgantown, WV, USA.
Förderung
- National Institute of General Medical Sciences
Zitieren
APA
Deusenberry, C. M., Bardsley, C., Sharon, M., Hobbs, G. R., Wilson, A. M., & Bardes, J. M. (2023). Low Molecular Weight Heparin Is Superior for Venous Thromboembolism Prophylaxis in High-Risk Geriatric Patients. The American Surgeon™. https://doi.org/10.1177/00031348231177922
Vancouver
Deusenberry CM, Bardsley C, Sharon M, Hobbs GR, Wilson AM, Bardes JM. Low Molecular Weight Heparin Is Superior for Venous Thromboembolism Prophylaxis in High-Risk Geriatric Patients. The American Surgeon™. 2023. doi:10.1177/00031348231177922
BibTeX
@article{Deusenberry2023,
author = {Deusenberry, Christina M and Bardsley, Casey and Sharon, Mindy and Hobbs, Gerald R and Wilson, Alison M and Bardes, James M},
title = {Low Molecular Weight Heparin Is Superior for Venous Thromboembolism Prophylaxis in High-Risk Geriatric Patients},
journal = {The American Surgeon™},
year = {2023},
doi = {10.1177/00031348231177922}
}
EUVIMED